3Z Pharmaceuticals
Reykjavík
About 3Z Pharmaceuticals
3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays. Karl Karlsson and Haraldur Thorsteinsson founded 3Z Pharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Funding stage: Seed
- Last round: Seed (Jun 2022)
- Website: 3z.is
- Phone: (354)599-6434
Industries & Categories
Consulting, Health Care, Medical, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/3z-pharmaceuticals-81126 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.